Keith M Sullivan
Keith M Sullivan
Association between Patient-reported Outcomes Prior to Chimeric Antigen Receptor (CAR) T-cell Therapy and Clinical Outcomes [0.03%]
CAR-T细胞治疗前患者报告结果与临床结局的相关性研究
Julia Garcia Mateo,Anna Barata,Tejaswini M Dhawale et al.
Julia Garcia Mateo et al.
Background: Chimeric antigen receptor T-cell therapy (CAR-T) is a transformative therapy for relapsed/refractory hematologic malignancies but often results in significant toxicities. While patient-reported outcomes (PROs)...
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE Study [0.03%]
系统性炎症和CAR-T特异性毒性是主要的非复发死亡驱动因素：意大利前瞻性观察性CART-SIE研究分析结果
Angelica Barone,Federico Stella,Silva Ljevar et al.
Angelica Barone et al.
Background: Chimeric antigen receptor (CAR)-T cell therapy has revolutionized outcomes in relapsed/refractory lymphomas, yet non-relapse mortality (NRM) has emerged as a notable concern, with older age and infections iden...
Novel FABT-Based Conditioning Regimen with Haploidentical Transplantation for Severe Aplastic Anemia: A prospective, single-center, phase II clinical trial [0.03%]
基于新型FABT方案预处理的单倍型移植治疗重型再生障碍性贫血：一项前瞻性单中心II期临床试验
Wenbin Liu,Zhengwei Tan,Yuechao Zhao et al.
Wenbin Liu et al.
Background: Haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) serves as an alternative treatment for severe aplastic anemia (SAA) patients lacking a suitable HLA-identical sibling donor. However, its dev...
Can cord blood unit selection improve outcomes after single-unit unrelated cord blood transplantation for non-remission acute myeloid leukemia? [0.03%]
选择脐血单位能否提高非完全缓解的急性髓系白血病单份无关脐血移植的疗效？
Takaaki Konuma,Yoshimitsu Shimomura,Satoshi Yamasaki et al.
Takaaki Konuma et al.
Background: Allogeneic hematopoietic cell transplantation (HCT) is the only established curative therapy for acute myeloid leukemia (AML) refractory to chemotherapy. Unrelated umbilical cord blood transplantation (CBT) pr...
Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study" [0.03%]
关于“门诊单倍型移植中早期免疫抑制作为CRS预防的随机II期研究”的来信回复
Perla R Colunga-Pedraza,Héctor A Vaquera-Alfaro,Andrés Gómez-De León et al.
Perla R Colunga-Pedraza et al.
HLA and Non‑HLA Factors in Haploidentical Donor Selection: Insights from a Brazilian Single‑Center Cohort [0.03%]
单中心巴西队列中半相合供者选择中的HLA和非HLA因素：见解
Newton de Freitas Centurião,Leonardo Javier Arcuri,Cinthya Corrêa da Silva et al.
Newton de Freitas Centurião et al.
Musculoskeletal Adverse Events Following BCMA CAR-T Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates [0.03%]
靶向BCMA的CAR-T细胞治疗多发性骨髓瘤后发生的肌肉骨骼不良事件的临床特征及免疫学关联研究
Amber Feng,Jian Wu,Taewoong Choi et al.
Amber Feng et al.
Background: Chimeric antigen receptor T-cell (CAR-T) therapy targeting B-cell maturation antigen (BCMA) has revolutionized treatment for relapsed/refractory multiple myeloma (RRMM). While life-threatening toxicities like ...
Incidence, Recurrence, Timing, and Economic Impact of Infections After CAR T-Cell Therapy: A Real-World Analysis from MarketScan Database [0.03%]
CAR-T细胞治疗后感染的发生率、复发、时间及经济影响：来自动态市场扫描数据库的现实世界分析
Mohammed Zuber,Shaimaa Elshafie,Daniel B Chastain et al.
Mohammed Zuber et al.
Background: Chimeric antigen receptor (CAR) T-cell therapy has transformed treatment of hematologic malignancies but causes profound immune dysfunction and a high infections risk. Real-world data on infection incidence an...
Fertility preservation in 2026: Current Landscape in Europe and the United States for Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation - Recommendations on behalf of the Westhafen Intercontinental Group [0.03%]
2026年生育力保存：欧洲和美国造血干细胞移植儿童和青少年的现状——Westhafen国际工作组推荐意见
Andrea Jarisch,Seth J Rotz,Alessandro Cattoni et al.
Andrea Jarisch et al.
Advances in hematopoietic stem cell transplantation (HSCT) and other cellular therapies have continued to better the long-term outcomes for pediatric patients undergoing these treatments. However, treatment impacts on future fertility can h...